Product Details

Verocort is a sterile injectable formulation that meets British Pharmacopoeia (BP) standards. Specifically, it delivers Hydrocortisone Sodium Succinate equivalent to 100mg Hydrocortisone per vial for use through the intramuscular (I.M.) or intravenous (I.V.) route. As a result, it offers a fast-acting corticosteroid for the management of acute inflammatory, allergic, and adrenal insufficiency conditions.

The injection contains:

• Hydrocortisone Sodium Succinate BP (equivalent to Hydrocortisone 100mg) – A synthetic corticosteroid with combined glucocorticoid and mild mineralocorticoid activity. Consequently, it suppresses inflammation, modulates immune response, and supports physiological cortisol replacement during states of adrenal insufficiency.

Physicians use Verocort for the emergency management of acute adrenal insufficiency, severe allergic reactions and anaphylaxis, acute asthma exacerbations, and various other conditions requiring rapid corticosteroid replacement or anti-inflammatory action. In addition, its dual-route (I.M./I.V.) formulation allows flexible administration based on clinical urgency. Because of this profile, Verocort suits hospitals, emergency departments, and ICUs where prompt corticosteroid intervention is essential.

Key Features:

• Overall, this BP-compliant formulation guarantees pharmaceutical-grade purity
• Additionally, the dual-route (I.M./I.V.) formulation offers flexible clinical use
• Furthermore, each single-dose vial delivers precise, validated dosage accuracy at 100mg
• Notably, rigorous purity and sterility testing backs every stage of manufacturing
• Beyond that, light-protected vial packaging preserves product stability during storage
• Ultimately, a reliable supply chain suits bulk distribution to hospitals, ICUs, and emergency care units